Total Payments
$362.91
2022 Payments
$39.78
Companies
6
Transactions
12
Medicare Patients
1,145
Medicare Billing
$165,043
Payment Breakdown by Category
Food & Beverage$362.91 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $362.91 | 12 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $164.49 | 3 | $0 (2022) |
| Allergan, Inc. | $78.54 | 5 | $0 (2021) |
| Boston Scientific Corporation | $76.11 | 1 | $0 (2019) |
| Daiichi Sankyo Inc. | $20.69 | 1 | $0 (2017) |
| US WorldMeds, LLC | $11.66 | 1 | $0 (2019) |
| Biosense Webster, Inc. | $11.42 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $39.78 | 2 | ABBVIE INC. ($39.78) |
| 2021 | $23.15 | 2 | Allergan, Inc. ($11.73) |
| 2020 | $15.15 | 1 | Allergan, Inc. ($15.15) |
| 2019 | $124.98 | 4 | Boston Scientific Corporation ($76.11) |
| 2018 | $139.16 | 2 | AbbVie, Inc. ($124.71) |
| 2017 | $20.69 | 1 | Daiichi Sankyo Inc. ($20.69) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/14/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: HYPERHYDROSIS | ||||||
| 05/17/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: HYPERHYDROSIS | ||||||
| 06/03/2021 | Biosense Webster, Inc. | Carto 3 (Device) | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: Cardiology | ||||||
| 02/26/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.73 | General |
| Category: HYPERHYDROSIS | ||||||
| 11/19/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: HYPERHYDROSIS | ||||||
| 09/05/2019 | US WorldMeds, LLC | APOKYN (Drug), Xadago | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: Neurology | ||||||
| 06/28/2019 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: HYPERHYDROSIS | ||||||
| 03/13/2019 | Boston Scientific Corporation | SPECTRA WAVEWRITER (Device) | Food and Beverage | In-kind items and services | $76.11 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/02/2019 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: HYPERHYDROSIS | ||||||
| 07/17/2018 | Allergan Inc. | BOTOX THERAPEUTIC (Biological) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: HYPERHYDROSIS | ||||||
| 05/08/2018 | AbbVie, Inc. | Lupron (Drug) | Food and Beverage | In-kind items and services | $124.71 | General |
| Category: Endocrinology | ||||||
| 08/24/2017 | Daiichi Sankyo Inc. | Movantik (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Opioid Induced Constipation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 305 | 593 | $112,921 | $41,548 |
| 2022 | 10 | 332 | 689 | $111,373 | $45,871 |
| 2021 | 9 | 337 | 704 | $125,082 | $52,629 |
| 2020 | 7 | 171 | 438 | $59,475 | $24,995 |
Total Patients
1,145
Total Services
2,424
Medicare Billing
$165,043
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 72 | 149 | $42,535 | $15,171 | 35.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 55 | 55 | $23,975 | $9,208 | 38.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 61 | $11,733 | $4,227 | 36.0% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 16 | 16 | $8,291 | $2,921 | 35.2% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 18 | 18 | $7,828 | $2,727 | 34.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 24 | 45 | $6,300 | $2,459 | 39.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 22 | 27 | $5,424 | $2,301 | 42.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 11 | $3,403 | $1,339 | 39.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 23 | $2,767 | $1,043 | 37.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 31 | 188 | $665.52 | $152.30 | 22.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 89 | 160 | $37,088 | $16,108 | 43.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 70 | 70 | $30,513 | $11,595 | 38.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 41 | 79 | $12,526 | $5,801 | 46.3% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 15 | 16 | $8,291 | $2,999 | 36.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 24 | 46 | $6,046 | $2,525 | 41.8% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 17 | 28 | $5,625 | $2,460 | 43.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $5,907 | $2,169 | 36.7% |
| 20526 | Injection of carpal tunnel | Office | 2022 | 11 | 17 | $2,788 | $1,186 | 42.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 14 | 18 | $1,747 | $818.37 | 46.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 34 | 238 | $842.52 | $210.14 | 24.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 94 | 188 | $43,578 | $19,217 | 44.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 84 | 84 | $36,616 | $14,681 | 40.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 43 | 77 | $12,209 | $5,728 | 46.9% |
| 20553 | Injections of trigger points in 3 or more muscles | Office | 2021 | 14 | 62 | $8,499 | $2,897 | 34.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 18 | 19 | $5,878 | $2,881 | 49.0% |
About Dr. Lisa Gleason, MD
Dr. Lisa Gleason, MD is a Physical Medicine & Rehabilitation healthcare provider based in Morro Bay, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/30/2007. The National Provider Identifier (NPI) number assigned to this provider is 1235330960.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lisa Gleason, MD has received a total of $362.91 in payments from pharmaceutical and medical device companies, with $39.78 received in 2022. These payments were reported across 12 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($362.91).
As a Medicare-enrolled provider, Gleason has provided services to 1,145 Medicare beneficiaries, totaling 2,424 services with total Medicare billing of $165,043. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Morro Bay, CA
- Active Since 05/30/2007
- Last Updated 11/02/2023
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1235330960
Products in Payments
- Lupron (Drug) $124.71
- BOTOX (Biological) $103.87
- SPECTRA WAVEWRITER (Device) $76.11
- Movantik (Drug) $20.69
- BOTOX THERAPEUTIC (Biological) $14.45
- APOKYN (Drug) $11.66
- Carto 3 (Device) $11.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.